Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Akebia Therapeutics (AKBA) Return on Invested Capital: 2019-2025

  • Akebia Therapeutics' Return on Invested Capital was N/A to 0.10% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.10%, marking a year-over-year change of. This contributed to the annual value of -0.53% for FY2019, which is 15.00% down from last year.
  • Latest data reveals that Akebia Therapeutics reported Return on Invested Capital of 0.10% as of Q3 2025, which was up 115.80% from -0.64% recorded in Q4 2019.
  • Akebia Therapeutics' 5-year Return on Invested Capital high stood at 0.10% for Q3 2025, and its period low was 0.10% during Q3 2025.
  • Over the past 1 years, Akebia Therapeutics' median Return on Invested Capital value was 0.10% (recorded in 2025), while the average stood at 0.10%.